| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 592,960 | 611,163 | 564,324 | | Cost of Revenue | 400,521 | 408,892 | 370,888 | | | Gross Profit | 192,439 | 202,271 | 193,436 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 154,671 | 177,468 | 178,703 | | Non Recurring | 5,611 | 5,546 | (305) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 32,157 | 19,257 | 15,038 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,182 | 5,489 | 4,387 | | Earnings Before Interest And Taxes | 34,339 | 24,746 | 19,425 | | Interest Expense | 2,863 | 1,136 | 31,955 | | Income Before Tax | 31,476 | 23,610 | (12,530) | | Income Tax Expense | 1,322 | 378 | 308 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,154 | 23,232 | (12,838) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 30,154 | 23,232 | (12,838) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,154 | $23,232 | ($12,838) |
|
1.48% Nasdaq 
Income Statement
